447 related articles for article (PubMed ID: 32823876)
1. Targeting Multiple Signaling Pathways in Cancer: The Rutin Therapeutic Approach.
Nouri Z; Fakhri S; Nouri K; Wallace CE; Farzaei MH; Bishayee A
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32823876
[TBL] [Abstract][Full Text] [Related]
2. An Overview of Biosynthetic Pathway and Therapeutic Potential of Rutin.
Goyal J; Verma PK
Mini Rev Med Chem; 2023; 23(14):1451-1460. PubMed ID: 36698235
[TBL] [Abstract][Full Text] [Related]
3. Rutin as a Potent Antioxidant: Implications for Neurodegenerative Disorders.
Enogieru AB; Haylett W; Hiss DC; Bardien S; Ekpo OE
Oxid Med Cell Longev; 2018; 2018():6241017. PubMed ID: 30050657
[TBL] [Abstract][Full Text] [Related]
4. Rutin (Bioflavonoid) as Cell Signaling Pathway Modulator: Prospects in Treatment and Chemoprevention.
Pandey P; Khan F; Qari HA; Oves M
Pharmaceuticals (Basel); 2021 Oct; 14(11):. PubMed ID: 34832851
[TBL] [Abstract][Full Text] [Related]
5. The anticancer potential of the dietary polyphenol rutin: Current status, challenges, and perspectives.
Farha AK; Gan RY; Li HB; Wu DT; Atanasov AG; Gul K; Zhang JR; Yang QQ; Corke H
Crit Rev Food Sci Nutr; 2022; 62(3):832-859. PubMed ID: 33054344
[TBL] [Abstract][Full Text] [Related]
6. Cellular senescence signaling in cancer: A novel therapeutic target to combat human malignancies.
Fakhri S; Zachariah Moradi S; DeLiberto LK; Bishayee A
Biochem Pharmacol; 2022 May; 199():114989. PubMed ID: 35288153
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2 Modulation in p53 Signaling Pathway by Flavonoids: A Potential Strategy towards the Treatment of Cancer.
Rahman N; Khan H; Zia A; Khan A; Fakhri S; Aschner M; Gul K; Saso L
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768743
[TBL] [Abstract][Full Text] [Related]
8. Exploring natural products-based cancer therapeutics derived from egyptian flora.
El-Seedi HR; Yosri N; Khalifa SAM; Guo Z; Musharraf SG; Xiao J; Saeed A; Du M; Khatib A; Abdel-Daim MM; Efferth T; Göransson U; Verpoorte R
J Ethnopharmacol; 2021 Apr; 269():113626. PubMed ID: 33248183
[TBL] [Abstract][Full Text] [Related]
9. The ameliorating effects of anthocyanins on the cross-linked signaling pathways of cancer dysregulated metabolism.
Fakhri S; Khodamorady M; Naseri M; Farzaei MH; Khan H
Pharmacol Res; 2020 Sep; 159():104895. PubMed ID: 32422342
[TBL] [Abstract][Full Text] [Related]
10. Potential Therapeutic Targets of Quercetin, a Plant Flavonol, and Its Role in the Therapy of Various Types of Cancer through the Modulation of Various Cell Signaling Pathways.
Almatroodi SA; Alsahli MA; Almatroudi A; Verma AK; Aloliqi A; Allemailem KS; Khan AA; Rahmani AH
Molecules; 2021 Mar; 26(5):. PubMed ID: 33804548
[TBL] [Abstract][Full Text] [Related]
11. Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance.
Fakhri S; Moradi SZ; Faraji F; Farhadi T; Hesami O; Iranpanah A; Webber K; Bishayee A
Cancer Metastasis Rev; 2023 Sep; 42(3):959-1020. PubMed ID: 37505336
[TBL] [Abstract][Full Text] [Related]
12. Targeting apoptosis and autophagy following spinal cord injury: Therapeutic approaches to polyphenols and candidate phytochemicals.
Abbaszadeh F; Fakhri S; Khan H
Pharmacol Res; 2020 Oct; 160():105069. PubMed ID: 32652198
[TBL] [Abstract][Full Text] [Related]
13. A Novel Approach to Unraveling the Apoptotic Potential of Rutin (Bioflavonoid) via Targeting
Pandey P; Khan F; Alzahrani FA; Qari HA; Oves M
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577000
[TBL] [Abstract][Full Text] [Related]
14. Quercetin- and rutin-based nano-formulations for cancer treatment: A systematic review of improved efficacy and molecular mechanisms.
Ghanbari-Movahed M; Mondal A; Farzaei MH; Bishayee A
Phytomedicine; 2022 Mar; 97():153909. PubMed ID: 35092896
[TBL] [Abstract][Full Text] [Related]
15. Anti-Cancerous Effect of Rutin Against HPV-C33A Cervical Cancer Cells via G0/G1 Cell Cycle Arrest and Apoptotic Induction.
Khan F; Pandey P; Upadhyay TK; Jafri A; Jha NK; Mishra R; Singh V
Endocr Metab Immune Disord Drug Targets; 2020; 20(3):409-418. PubMed ID: 31385777
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant and anticancer potentials of edible flowers: where do we stand?
Fakhri S; Tomas M; Capanoglu E; Hussain Y; Abbaszadeh F; Lu B; Hu X; Wu J; Zou L; Smeriglio A; Simal-Gandara J; Cao H; Xiao J; Khan H
Crit Rev Food Sci Nutr; 2022; 62(31):8589-8645. PubMed ID: 34096420
[TBL] [Abstract][Full Text] [Related]
17. Blockade of oxidized LDL-triggered endothelial apoptosis by quercetin and rutin through differential signaling pathways involving JAK2.
Choi JS; Kang SW; Li J; Kim JL; Bae JY; Kim DS; Shin SY; Jun JG; Wang MH; Kang YH
J Agric Food Chem; 2009 Mar; 57(5):2079-86. PubMed ID: 19196000
[TBL] [Abstract][Full Text] [Related]
18. A review on plant-based rutin extraction methods and its pharmacological activities.
Chua LS
J Ethnopharmacol; 2013 Dec; 150(3):805-17. PubMed ID: 24184193
[TBL] [Abstract][Full Text] [Related]
19. Anticancer effects of rutin from Fagopyrum tataricum (tartary buckwheat) against osteosarcoma cell line.
Soosai D; Ramalingam R; Perumal E; Veeramani K; Pancras C; Almutairi MH; Savarimuthu LAR; Veeramuthu D; Antony S
Mol Biol Rep; 2024 Feb; 51(1):312. PubMed ID: 38374412
[TBL] [Abstract][Full Text] [Related]
20. The flavonoid rutin and its aglycone quercetin modulate the microglia inflammatory profile improving antiglioma activity.
da Silva AB; Cerqueira Coelho PL; das Neves Oliveira M; Oliveira JL; Oliveira Amparo JA; da Silva KC; Soares JRP; Pitanga BPS; Dos Santos Souza C; de Faria Lopes GP; da Silva VDA; de Fátima Dias Costa M; Junier MP; Chneiweiss H; Moura-Neto V; Costa SL
Brain Behav Immun; 2020 Mar; 85():170-185. PubMed ID: 31059805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
